Efficacy and safety of combination therapy with tolvaptan and dapagliflozin in patients with acute decompensated heart failure: A randomized controled trial
Not Applicable
Recruiting
- Conditions
- Acute decompensated heart failure
- Registration Number
- JPRN-UMIN000039340
- Lead Sponsor
- Kansai Medical University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Not provided
Exclusion Criteria
Patients with acute coronary syndrome Patients with out-of-hospital cardiac arrest No tolerability of tolvaptan or dapagliflozin Rejected study enrollment
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method